REYON PHARMACEUTICAL CO., LTD Logo

REYON PHARMACEUTICAL CO., LTD

Develops & makes APIs, generics, cell/gene therapies, and offers biopharma CDMO services.

102460 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로 620 에이동 12층 (대치동, 미래에셋타워), 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Reyon Pharmaceutical Co., Ltd. is an integrated pharmaceutical company focused on the research, development, and manufacturing of both chemical and biopharmaceutical products. The company's core business includes the production of Active Pharmaceutical Ingredients (APIs) and finished generic formulations, such as injections, tablets, and antibiotics. Strategically expanding into next-generation therapeutics, Reyon is actively developing advanced treatments in areas like AAV gene therapy for conditions such as wet age-related macular degeneration (wAMD) and NK cell therapy for solid cancers. A significant part of its growth strategy involves its biopharmaceutical Contract Development and Manufacturing Organization (CDMO) services, which are being scaled through strategic partnerships to support the production of complex biologics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.5 MB
2025-08-01 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.9 MB
2025-07-25 00:00
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 12.2 KB
2025-07-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 92.2 KB
2025-06-02 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 1.8 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-25 00:00
Share Issue/Capital Change
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 10.9 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.3 KB
2025-03-24 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 2.1 MB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 20.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 629.3 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 14.8 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 1.1 MB
2025-03-14 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 1.0 MB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.9 KB

Automate Your Workflow. Get a real-time feed of all REYON PHARMACEUTICAL CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for REYON PHARMACEUTICAL CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.